{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:38:20Z","timestamp":1790678300028,"version":"4.1.0"},"reference-count":181,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7261","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:11:54Z","timestamp":1508775114000},"source":"Crossref","is-referenced-by-count":10,"title":["Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)"],"prefix":"10.3892","author":[{"given":"Magdalena","family":"Szary\u0144ska","sequence":"first","affiliation":[{"name":"Department of Histology, Medical University of Gda\u0144sk, 80\u2011210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Olejniczak","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gda\u0144sk, 80\u2011210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Kobiela","sequence":"additional","affiliation":[{"name":"Department of General, Endocrine and Transplant Surgery, Invasive Medicine Center, Medical University of Gda\u0144sk, 80\u2011214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Spychalski","sequence":"additional","affiliation":[{"name":"Department of General, Endocrine and Transplant Surgery, Invasive Medicine Center, Medical University of Gda\u0144sk, 80\u2011214 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Kmie\u0107","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gda\u0144sk, 80\u2011210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"key20200714001143_b1-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"12094","DOI":"10.3390\/ijms150712094","article-title":"Flavonoids and Wnt\/\u03b2-catenin signaling: Potential role in colorectal cancer therapies","volume":"15","author":"Amado","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20200714001143_b2-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1007\/s13277-016-5232-6","article-title":"Characterization of cancer stem cells from different grades of human colorectal cancer","volume":"37","author":"Manhas","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714001143_b3-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mam.2013.07.001","article-title":"Colorectal cancer defeating?","volume":"39","author":"Di Franco","year":"2014","journal-title":"Mol Aspects Med"},{"key":"key20200714001143_b4-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"key20200714001143_b5-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/annonc\/mdu260","article-title":"Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Van Cutsem","year":"2014","journal-title":"Ann Oncol"},{"key":"key20200714001143_b6-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S1470-2045(14)70227-X","article-title":"Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): An open-label, randomised phase 3 trial","volume":"15","author":"Taieb","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20200714001143_b7-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.3748\/wjg.v20.i22.6786","article-title":"Colorectal cancer: From prevention to personalized medicine","volume":"20","author":"Binefa","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b8-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200714001143_b9-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"12391","DOI":"10.3748\/wjg.v20.i35.12391","article-title":"Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone?","volume":"20","author":"Khan","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b10-ol-0-0-7261","first-page":"859871","article-title":"Tumor initiating cells and chemoresistance: Which is the best strategy to target colon cancer stem cells?","author":"Paldino","year":"2014","journal-title":"Biomed Res Int 2014"},{"key":"key20200714001143_b11-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"key20200714001143_b12-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/path.2954","article-title":"Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells","volume":"225","author":"Puglisi","year":"2011","journal-title":"J Pathol"},{"key":"key20200714001143_b13-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"key20200714001143_b14-ol-0-0-7261","first-page":"2111","article-title":"CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors","volume":"118","author":"Shmelkov","year":"2008","journal-title":"J Clin Invest"},{"key":"key20200714001143_b15-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4161\/cc.7.3.5389","article-title":"IL-4-mediated drug resistance in colon cancer stem cells","volume":"7","author":"Todaro","year":"2008","journal-title":"Cell Cycle"},{"key":"key20200714001143_b16-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","article-title":"Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714001143_b17-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2012.08.036","article-title":"Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis","volume":"328","author":"Lin","year":"2013","journal-title":"Cancer Lett"},{"key":"key20200714001143_b18-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cbin.10049","article-title":"Intestinal stem cells-types and markers","volume":"37","author":"Zhang","year":"2013","journal-title":"Cell Biol Int"},{"key":"key20200714001143_b19-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","article-title":"Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition","volume":"69","author":"Dallas","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714001143_b20-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molmed.2008.09.005","article-title":"Colon cancer stem cells: Implications for prevention and therapy","volume":"14","author":"Huang","year":"2008","journal-title":"Trends Mol Med"},{"key":"key20200714001143_b21-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/DCR.0b013e31827c2b80","article-title":"Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma","volume":"56","author":"Yu","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"key20200714001143_b22-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","article-title":"Colon cancer: Cancer stem cells markers, drug resistance and treatment","volume":"68","author":"Kozovska","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"key20200714001143_b23-ol-0-0-7261","unstructured":"VermeulenLTodaroMde Sousa MelloFSprickMRKemperKPerez AleaMRichelDJStassiGMedemaJPSingle-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacityProc Natl Acad Sci USA1051342713432200810.1073\/pnas.080570610518765800"},{"key":"key20200714001143_b24-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/modpathol.2009.181","article-title":"CD133 expression predicts for non-response to chemotherapy in colorectal cancer","volume":"23","author":"Ong","year":"2010","journal-title":"Mod Pathol"},{"key":"key20200714001143_b25-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00432-012-1253-8","article-title":"Nanog siRNA plus cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer","volume":"138","author":"Du","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200714001143_b26-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1158\/1078-0432.CCR-08-1034","article-title":"CD44 is of functional importance for colorectal cancer stem cells","volume":"14","author":"Du","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200714001143_b27-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.critrevonc.2017.01.007","article-title":"Serum and tissue markers in colorectal cancer: State of art","volume":"111","author":"Berretta","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200714001143_b28-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3892\/or_00000885","article-title":"Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance","volume":"24","author":"Honoki","year":"2010","journal-title":"Oncol Rep"},{"key":"key20200714001143_b29-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"e20636","DOI":"10.1371\/journal.pone.0020636","article-title":"ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"key20200714001143_b30-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: A comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharmacol Rev"},{"key":"key20200714001143_b31-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1158\/1055-9965.EPI-09-0865","article-title":"Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer","volume":"19","author":"Su","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20200714001143_b32-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","article-title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells","volume":"133","author":"Croker","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"key20200714001143_b33-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1182\/blood-2009-01-198911","article-title":"Differentiation therapy of leukemia: 3 decades of development","volume":"113","author":"Nowak","year":"2009","journal-title":"Blood"},{"key":"key20200714001143_b34-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3892\/ijo.2016.3546","article-title":"Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase","volume":"49","author":"Chung","year":"2016","journal-title":"Int J Oncol"},{"key":"key20200714001143_b35-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.18632\/oncotarget.2475","article-title":"Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: A strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy","volume":"5","author":"Martino-Echarri","year":"2014","journal-title":"Oncotarget"},{"key":"key20200714001143_b36-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"key20200714001143_b37-ol-0-0-7261","first-page":"58","article-title":"microRNAs and cancer metabolism reprogramming: The paradigm of metformin","volume":"2","author":"Pulito","year":"2014","journal-title":"Ann Transl Med"},{"key":"key20200714001143_b38-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"key20200714001143_b39-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"key20200714001143_b40-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexcr.2012.11.004","article-title":"Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGF\u03b21-targeting peptides P17 and P144","volume":"319","author":"Zubeldia","year":"2013","journal-title":"Exp Cell Res"},{"key":"key20200714001143_b41-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"key20200714001143_b42-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"pii: E60","DOI":"10.3390\/cancers8070060","article-title":"Wnt signaling in cancer stem cell biology","volume":"8","author":"de Sousa","year":"2016","journal-title":"Cancers (Basel)"},{"key":"key20200714001143_b43-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20200714001143_b44-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5603\/FHC.a2015.0015","article-title":"The Hippo pathway in colorectal cancer","volume":"53","author":"Wierzbicki","year":"2015","journal-title":"Folia Histochem Cytobiol"},{"key":"key20200714001143_b45-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature10408","article-title":"A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable","volume":"478","author":"Tian","year":"2011","journal-title":"Nature"},{"key":"key20200714001143_b46-ol-0-0-7261","unstructured":"YanKSChiaLALiXOotaniASuJLeeJYSuNLuoYHeilshornSCAmievaMRThe intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populationsProc Natl Acad Sci USA109466471201210.1073\/pnas.111885710922190486"},{"key":"key20200714001143_b47-ol-0-0-7261","first-page":"1355","article-title":"Proof-of-principle: Oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors","volume":"1","author":"Kim","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"key20200714001143_b48-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/15384047.2016.1195045","article-title":"Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer","volume":"17","author":"Huynh","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"key20200714001143_b49-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nchembio.453","article-title":"Small-molecule inhibition of Wnt signaling through activation of casein kinase 1\u03b1","volume":"6","author":"Thorne","year":"2010","journal-title":"Nat Chem Biol"},{"key":"key20200714001143_b50-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Chem Biol"},{"key":"key20200714001143_b51-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"key20200714001143_b52-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nrd3868","article-title":"Tankyrase-targeted therapeutics: Expanding opportunities in the PARP family","volume":"11","author":"Riffell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"key20200714001143_b53-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/emboj.2012.126","article-title":"Drugging Wnt signalling in cancer","volume":"31","author":"Polakis","year":"2012","journal-title":"EMBO J"},{"key":"key20200714001143_b54-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/0008-5472.CAN-11-3336","article-title":"A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice","volume":"72","author":"Waaler","year":"2012","journal-title":"Cancer Res"},{"key":"key20200714001143_b55-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1158\/0008-5472.CAN-12-4562","article-title":"A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth","volume":"73","author":"Lau","year":"2013","journal-title":"Cancer Res"},{"key":"key20200714001143_b56-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/0192623315621192","article-title":"Tankyrase inhibition causes reversible intestinal toxicity in mice with a therapeutic index <1","volume":"44","author":"Zhong","year":"2016","journal-title":"Toxicol Pathol"},{"key":"key20200714001143_b57-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cas.12471","article-title":"Safely targeting cancer stem cells via selective catenin coactivator antagonism","volume":"105","author":"Lenz","year":"2014","journal-title":"Cancer Sci"},{"key":"key20200714001143_b58-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","article-title":"The Wnt signaling pathway in cancer","volume":"99","author":"Duchartre","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200714001143_b59-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/0008-5472.CAN-15-1519","article-title":"A small-molecule antagonist of the \u03b2-catenin\/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis","volume":"76","author":"Fang","year":"2016","journal-title":"Cancer Res"},{"key":"key20200714001143_b60-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.18632\/oncotarget.3464","article-title":"Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer","volume":"6","author":"Aguilera","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714001143_b61-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/sj.onc.1208303","article-title":"The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin\/TCF and is downregulated in human colon cancer","volume":"24","author":"Gonz\u00e1lez-Sancho","year":"2005","journal-title":"Oncogene"},{"key":"key20200714001143_b62-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1349-7006.2012.02222.x","article-title":"Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression","volume":"103","author":"Qi","year":"2012","journal-title":"Cancer Sci"},{"key":"key20200714001143_b63-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20200714001143_b64-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/his.12474","article-title":"Dickkopf-1 expression is down-regulated during the colorectal adenoma-carcinoma sequence and correlates with reduced microvessel density and VEGF expression","volume":"67","author":"Liu","year":"2015","journal-title":"Histopathology"},{"key":"key20200714001143_b65-ol-0-0-7261","unstructured":"RodillaVVillanuevaAObrador-HeviaARobert-MorenoAFern\u00e1ndez-MajadaVGrilliAL\u00f3pez-BigasNBelloraNAlb\u00e0MMTorresFJagged1 is the pathological link between Wnt and Notch pathways in colorectal cancerProc Natl Acad Sci USA10663156320200910.1073\/pnas.081322110619325125"},{"key":"key20200714001143_b66-ol-0-0-7261","first-page":"635","article-title":"Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin","volume":"18","author":"Atashpour","year":"2015","journal-title":"Iran J Basic Med Sci"},{"key":"key20200714001143_b67-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"17279","DOI":"10.3390\/ijms140917279","article-title":"Potential targets for colorectal cancer prevention","volume":"14","author":"Temraz","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20200714001143_b68-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/jmf.2010.0310","article-title":"Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3\u03b2 enzymatic activity by lowering the interaction energy within the binding cavity","volume":"14","author":"Johnson","year":"2011","journal-title":"J Med Food"},{"key":"key20200714001143_b69-ol-0-0-7261","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2016.62","article-title":"Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients","author":"Ning","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"key20200714001143_b70-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-09-3249","article-title":"Chemoprevention of intestinal tumorigenesis in APCmin\/+ mice by silibinin","volume":"70","author":"Rajamanickam","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714001143_b71-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1593\/neo.10188","article-title":"Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling","volume":"12","author":"Kaur","year":"2010","journal-title":"Neoplasia"},{"key":"key20200714001143_b72-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-05-2724","article-title":"Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: Silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences","volume":"12","author":"Hoh","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20200714001143_b73-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.18632\/oncotarget.2068","article-title":"Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4\/6-mediated survival signals","volume":"5","author":"Kumar","year":"2014","journal-title":"Oncotarget"},{"key":"key20200714001143_b74-ol-0-0-7261","first-page":"1207","article-title":"Targeting cancer stem cells: Emerging role of Nanog transcription factor","volume":"6","author":"Wang","year":"2013","journal-title":"Onco Targets Ther"},{"key":"key20200714001143_b75-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/stem.1182","article-title":"Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms","volume":"30","author":"Ibrahim","year":"2012","journal-title":"Stem Cells"},{"key":"key20200714001143_b76-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1038\/onc.2012.461","article-title":"NANOG modulates stemness in human colorectal cancer","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"key20200714001143_b77-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2011.06.005","article-title":"CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation","volume":"9","author":"Lee","year":"2011","journal-title":"Cell Stem Cell"},{"key":"key20200714001143_b78-ol-0-0-7261","first-page":"593","article-title":"Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells","volume":"26","author":"Niu","year":"2011","journal-title":"Oncol Rep"},{"key":"key20200714001143_b79-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PGP.0b013e3182055a1f","article-title":"Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma","volume":"30","author":"Zhou","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"key20200714001143_b80-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1096\/fj.08-102590","article-title":"Identification of a tumor-initiating stem cell population in human renal carcinomas","volume":"22","author":"Bussolati","year":"2008","journal-title":"FASEB J"},{"key":"key20200714001143_b81-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Jeter","year":"2011","journal-title":"Oncogene"},{"key":"key20200714001143_b82-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/emboj.2010.137","article-title":"NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53","volume":"29","author":"Zbinden","year":"2010","journal-title":"EMBO J"},{"key":"key20200714001143_b83-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.9.4.10666","article-title":"Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer","volume":"9","author":"Meng","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"key20200714001143_b84-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.anndiagpath.2016.09.012","article-title":"A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues","volume":"25","author":"\u00d6zg\u00fcl \u00d6zdemir","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"key20200714001143_b85-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2012.02.021","article-title":"RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0\/G1 cell cycle arrest in breast cancer cells","volume":"321","author":"Han","year":"2012","journal-title":"Cancer Lett"},{"key":"key20200714001143_b86-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1002\/jcp.24076","article-title":"Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells","volume":"227","author":"Choi","year":"2012","journal-title":"J Cell Physiol"},{"key":"key20200714001143_b87-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1158\/1078-0432.CCR-14-1134","article-title":"Inhibition of NANOG\/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics","volume":"20","author":"Mattoo","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20200714001143_b88-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","article-title":"Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation","volume":"70","author":"Chiou","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714001143_b89-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2017.01.039","article-title":"Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT)","volume":"392","author":"Pan","year":"2017","journal-title":"Cancer Lett"},{"key":"key20200714001143_b90-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13277-015-3198-4","article-title":"Biomarkers and signaling pathways of colorectal cancer stem cells","volume":"36","author":"Abetov","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200714001143_b91-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"pii: E11","DOI":"10.3390\/jcm6010011","article-title":"TGF-\u03b2 signaling in gastrointestinal cancers: Progress in basic and clinical research","volume":"6","author":"Yokobori","year":"2017","journal-title":"J Clin Med"},{"key":"key20200714001143_b92-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4049\/jimmunol.181.1.126","article-title":"In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1","volume":"181","author":"Gil-Guerrero","year":"2008","journal-title":"J Immunol"},{"key":"key20200714001143_b93-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/ijc.24656","article-title":"Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy","volume":"125","author":"Llopiz","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200714001143_b94-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00441-014-2075-6","article-title":"Co-migration of colon cancer cells and CAFs induced by TGF\u03b21 enhances liver metastasis","volume":"359","author":"Gonzalez-Zubeldia","year":"2015","journal-title":"Cell Tissue Res"},{"key":"key20200714001143_b95-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11427-014-4775-2","article-title":"Kindler syndrome protein Kindlin-1 is mainly expressed in adult tissues originating from ectoderm\/endoderm","volume":"58","author":"Zhan","year":"2015","journal-title":"Sci China Life Sci"},{"key":"key20200714001143_b96-ol-0-0-7261","doi-asserted-by":"crossref","first-page":"76224","DOI":"10.18632\/oncotarget.12779","article-title":"Focal adhesion molecule Kindlin-1 mediates activation of TGF-\u03b2 signaling by interacting with TGF-\u03b2RI, SARA and Smad3 in colorectal cancer cells","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714001143_b97-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s13277-015-3988-8","article-title":"BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice","volume":"37","author":"Karagiannis","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714001143_b98-ol-0-0-7261","first-page":"2744","article-title":"Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res"},{"key":"key20200714001143_b99-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"E1928","DOI":"10.1002\/humu.21376","article-title":"Evaluation of germline BMP4 mutation as a cause of colorectal cancer","volume":"32","author":"Lubbe","year":"2011","journal-title":"Hum Mutat"},{"key":"key20200714001143_b100-ol-0-0-7261","unstructured":"KosinskiCLiVSChanASZhangJHoCTsuiWYChanTLMifflinRCPowellDWYuenSTGene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factorsProc Natl Acad Sci USA1041541815423200710.1073\/pnas.070721010417881565"},{"key":"key20200714001143_b101-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/mmr.2014.2216","article-title":"Colorectal polyp model established by transplacental BMP4 RNAi","volume":"10","author":"Jin","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20200714001143_b102-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13277-010-0023-y","article-title":"Emerging strategies for the identification and targeting of cancer stem cells","volume":"31","author":"Dou","year":"2010","journal-title":"Tumour Biol"},{"key":"key20200714001143_b103-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2010.10.005","article-title":"Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice","volume":"140","author":"Lombardo","year":"2011","journal-title":"Gastroenterology"},{"key":"key20200714001143_b104-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cyto.2014.12.021","article-title":"Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies","volume":"72","author":"Zhou","year":"2015","journal-title":"Cytokine"},{"key":"key20200714001143_b105-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"20540","DOI":"10.18632\/oncotarget.4110","article-title":"Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth","volume":"6","author":"Shi","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714001143_b106-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-2187-2-4","article-title":"Role of RGM coreceptors in bone morphogenetic protein signaling","volume":"2","author":"Halbrooks","year":"2007","journal-title":"J Mol Signal"},{"key":"key20200714001143_b107-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/0008-5472.CAN-15-1542","article-title":"Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling","volume":"76","author":"Catalano","year":"2016","journal-title":"Cancer Res"},{"key":"key20200714001143_b108-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1111\/j.1349-7006.2011.02049.x","article-title":"Role of Notch signaling in colon homeostasis and carcinogenesis","volume":"102","author":"Miyamoto","year":"2011","journal-title":"Cancer Sci"},{"key":"key20200714001143_b109-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-09-2557","article-title":"NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer","volume":"70","author":"Sikandar","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714001143_b110-ol-0-0-7261","first-page":"1223","article-title":"Activation of Notch signaling in human colon adenocarcinoma","volume":"33","author":"Reedijk","year":"2008","journal-title":"Int J Oncol"},{"key":"key20200714001143_b111-ol-0-0-7261","unstructured":"FreSPallaviSKHuygheMLa\u00e9MJanssenKPRobineSArtavanis-TsakonasSLouvardDNotch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestineProc Natl Acad Sci USA10663096314200910.1073\/pnas.090042710619251639"},{"key":"key20200714001143_b112-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.stem.2009.05.019","article-title":"DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency","volume":"5","author":"Hoey","year":"2009","journal-title":"Cell Stem Cell"},{"key":"key20200714001143_b113-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00432-013-1534-x","article-title":"Dll4-Notch signaling in regulation of tumor angiogenesis","volume":"140","author":"Liu","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20200714001143_b114-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/nature08751","article-title":"Chronic DLL4 blockade induces vascular neoplasms","volume":"463","author":"Yan","year":"2010","journal-title":"Nature"},{"key":"key20200714001143_b115-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-10-2817","article-title":"Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations","volume":"71","author":"Fischer","year":"2011","journal-title":"Cancer Res"},{"key":"key20200714001143_b116-ol-0-0-7261","first-page":"6510","article-title":"HDAC5 promotes colorectal cancer cell proliferation by up-regulating DLL4 expression","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200714001143_b117-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ncb2581","article-title":"Dll1+ secretory progenitor cells revert to stem cells upon crypt damage","volume":"14","author":"van Es","year":"2012","journal-title":"Nat Cell Biol"},{"key":"key20200714001143_b118-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nature03589","article-title":"Notch signals control the fate of immature progenitor cells in the intestine","volume":"435","author":"Fre","year":"2005","journal-title":"Nature"},{"key":"key20200714001143_b119-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.gene.2015.10.065","article-title":"Jagged1 (JAG1): Structure, expression, and disease associations","volume":"576","author":"Grochowski","year":"2016","journal-title":"Gene"},{"key":"key20200714001143_b120-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","article-title":"Notch signalling: A simple pathway becomes complex","volume":"7","author":"Bray","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200714001143_b121-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nature03659","article-title":"Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"key20200714001143_b122-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/onc.2009.393","article-title":"Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: Implications for targeting Notch signaling","volume":"29","author":"Guilmeau","year":"2010","journal-title":"Oncogene"},{"key":"key20200714001143_b123-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2012.12.021","article-title":"Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1","volume":"23","author":"Lu","year":"2013","journal-title":"Cancer Cell"},{"key":"key20200714001143_b124-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3892\/mmr.2015.3694","article-title":"Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor","volume":"12","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200714001143_b125-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/0008-5472.CAN-08-2088","article-title":"Gamma-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity","volume":"69","author":"Meng","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714001143_b126-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2010.10.006","article-title":"Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells","volume":"300","author":"Akao","year":"2011","journal-title":"Cancer Lett"},{"key":"key20200714001143_b127-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/CS20100587","article-title":"Cellular and molecular effects of sirtuins in health and disease","volume":"121","author":"Horio","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"key20200714001143_b128-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijsu.2016.01.002","article-title":"Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis","volume":"26","author":"Zu","year":"2016","journal-title":"Int J Surg"},{"key":"key20200714001143_b129-ol-0-0-7261","unstructured":"YamakuchiMFerlitoMLowensteinCJmiR-34a repression of SIRT1 regulates apoptosisProc Natl Acad Sci USA1051342113426200810.1073\/pnas.080161310518755897"},{"key":"key20200714001143_b130-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.3748\/wjg.v20.i33.11727","article-title":"MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer","volume":"20","author":"Stiegelbauer","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b131-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1038\/srep07481","article-title":"High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"key20200714001143_b132-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/ars.2016.6750","article-title":"Heterogeneity in cancer metabolism: New concepts in an old field","volume":"26","author":"Gentric","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"key20200714001143_b133-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.advenzreg.2009.10.027","article-title":"The altered metabolism of tumors: HIF-1 and its role in the Warburg effect","volume":"50","author":"Stubbs","year":"2010","journal-title":"Adv Enzyme Regul"},{"key":"key20200714001143_b134-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"59503","DOI":"10.18632\/oncotarget.11147","article-title":"Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714001143_b135-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4161\/cc.24479","article-title":"The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells","volume":"12","author":"Menendez","year":"2013","journal-title":"Cell Cycle"},{"key":"key20200714001143_b136-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting cancer cell metabolism: The combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"70","author":"Ben Sahra","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714001143_b137-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: A new perspective for an old antidiabetic drug?","volume":"9","author":"Ben Sahra","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key20200714001143_b138-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clcc.2016.04.011","article-title":"Phase 2 trial of metformin combined with 5-fluorouracil in patients with refractory metastatic colorectal cancer","volume":"15","author":"Miranda","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"key20200714001143_b139-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00280-016-3037-3","article-title":"Combinational strategies of metformin and chemotherapy in cancers","volume":"78","author":"Zhang","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20200714001143_b140-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1158\/1940-6207.PREV-10-B53","article-title":"Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial","volume":"3","author":"Hosono","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20200714001143_b141-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"e81264","DOI":"10.1371\/journal.pone.0081264","article-title":"Effects of metformin on CD133+ colorectal cancer cells in diabetic patients","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"key20200714001143_b142-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12263-015-0499-6","article-title":"Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells","volume":"10","author":"Montales","year":"2015","journal-title":"Genes Nutr"},{"key":"key20200714001143_b143-ol-0-0-7261","first-page":"1935","article-title":"Effects of metformin on proliferation of human colon carcinoma cell line SW-480","volume":"30","author":"Zhou","year":"1942","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20200714001143_b144-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1080\/13880209.2016.1176057","article-title":"Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: A meta-analysis","volume":"54","author":"Nie","year":"2016","journal-title":"Pharm Biol"},{"key":"key20200714001143_b145-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cncr.29165","article-title":"Metformin for primary colorectal cancer prevention in patients with diabetes: A case-control study in a US population","volume":"121","author":"Sehdev","year":"2015","journal-title":"Cancer"},{"key":"key20200714001143_b146-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5217\/ir.2014.12.2.139","article-title":"Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?","volume":"12","author":"Cho","year":"2014","journal-title":"Intest Res"},{"key":"key20200714001143_b147-ol-0-0-7261","first-page":"e52801","article-title":"Studying pancreatic cancer stem cell characteristics for developing new treatment strategies","author":"Lonardo","year":"2015","journal-title":"J Vis Exp"},{"key":"key20200714001143_b148-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res"},{"key":"key20200714001143_b149-ol-0-0-7261","unstructured":"HirschHAIliopoulosDStruhlKMetformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growthProc Natl Acad Sci USA110972977201310.1073\/pnas.122105511023277563"},{"key":"key20200714001143_b150-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"key20200714001143_b151-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.4161\/cc.9.18.13131","article-title":"Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status","volume":"9","author":"Vazquez-Martin","year":"2010","journal-title":"Cell Cycle"},{"key":"key20200714001143_b152-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"e97781","DOI":"10.1371\/journal.pone.0097781","article-title":"Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation","volume":"9","author":"Sui","year":"2014","journal-title":"PLoS One"},{"key":"key20200714001143_b153-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldw028","article-title":"The role of aspirin in preventing colorectal cancer","volume":"119","author":"Burn","year":"2016","journal-title":"Br Med Bull"},{"key":"key20200714001143_b154-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jama.2015.1815","article-title":"Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants","volume":"313","author":"Nan","year":"2015","journal-title":"JAMA"},{"key":"key20200714001143_b155-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.3748\/wjg.v20.i23.7137","article-title":"Emerging role of the \u03b2-catenin-PPAR\u03b3 axis in the pathogenesis of colorectal cancer","volume":"20","author":"Sabatino","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b156-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.onc.1204123","article-title":"The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin\/TCF-4 signaling","volume":"20","author":"Dihlmann","year":"2001","journal-title":"Oncogene"},{"key":"key20200714001143_b157-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/carcin\/23.1.107","article-title":"Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells","volume":"23","author":"Hawcroft","year":"2002","journal-title":"Carcinogenesis"},{"key":"key20200714001143_b158-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2012.385","article-title":"Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: A randomized trial","volume":"307","author":"Alberts","year":"2012","journal-title":"JAMA"},{"key":"key20200714001143_b159-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12032-014-0325-9","article-title":"A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer","volume":"32","author":"Cao","year":"2015","journal-title":"Med Oncol"},{"key":"key20200714001143_b160-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20200714001143_b161-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S1470-2045(13)70490-X","article-title":"Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): An open-label, non-inferiority, randomised phase 3 trial","volume":"14","author":"Yamada","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20200714001143_b162-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1200\/JCO.2015.60.9107","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil\/folinic acid as adjuvant therapy for stage iii colon cancer: Final results of the NO16968 randomized controlled phase III trial","volume":"33","author":"Schmoll","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20200714001143_b163-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/annonc\/mdu474","article-title":"Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: The randomised phase I\/II POSEIDON trial","volume":"26","author":"\u00c9lez","year":"2015","journal-title":"Ann Oncol"},{"key":"key20200714001143_b164-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"djv258","DOI":"10.1093\/jnci\/djv258","article-title":"A randomized phase II\/III study of dalotuzumab in combination with cetuximab and irinotecan in chemorefractory, KRAS wild-type, metastatic colorectal cancer","volume":"107","author":"Sclafani","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"key20200714001143_b165-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"12234","DOI":"10.3748\/wjg.v21.i43.12234","article-title":"Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer","volume":"21","author":"Fujita","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b166-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1470-2045(12)70509-0","article-title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): A phase 3 randomised controlled trial","volume":"13","author":"de Gramont","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20200714001143_b167-ol-0-0-7261","first-page":"385","article-title":"Uracil\/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: A single institutional retrospective study","volume":"19","author":"Bayoglu","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"key20200714001143_b168-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.3748\/wjg.v20.i15.4263","article-title":"Anti-EGFR and anti-VEGF agents: Important targeted therapies of colorectal liver metastases","volume":"20","author":"Feng","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200714001143_b169-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1634\/theoncologist.2011-0358","article-title":"Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancer","volume":"17","author":"Strickler","year":"2012","journal-title":"Oncologist"},{"key":"key20200714001143_b170-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejca.2017.01.026","article-title":"The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials","volume":"75","author":"Roviello","year":"2017","journal-title":"Eur J Cancer"},{"key":"key20200714001143_b171-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clcc.2013.12.002","article-title":"Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147","volume":"13","author":"Huang","year":"2014","journal-title":"Clin Colorectal Cancer"},{"key":"key20200714001143_b172-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1111\/ajco.12405","article-title":"Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients","volume":"13","author":"Terazawa","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"key20200714001143_b173-ol-0-0-7261","first-page":"189","article-title":"Treatment of metastatic colorectal cancer: Focus on panitumumab","volume":"7","author":"Tay","year":"2015","journal-title":"Cancer Manag Res"},{"key":"key20200714001143_b174-ol-0-0-7261","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25952","article-title":"Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer","author":"Bahrami","year":"2017","journal-title":"J Cell Physiol"},{"key":"key20200714001143_b175-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/DDDT.S119036","article-title":"Immunotherapy for the treatment of colorectal tumors: Focus on approved and in-clinical-trial monoclonal antibodies","volume":"11","author":"Fran\u00e7oso","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"key20200714001143_b176-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/PPO.0000000000000188","article-title":"Adjuvant therapy trials","volume":"22","author":"Ursem","year":"2016","journal-title":"Cancer J"},{"key":"key20200714001143_b177-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2012.04.006","article-title":"Colon cancer stem cells-from basic to clinical application","volume":"338","author":"Botchkina","year":"2013","journal-title":"Cancer Lett"},{"key":"key20200714001143_b178-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1245\/s10434-008-0074-0","article-title":"CD133+CD44+ population efficiently enriches colon cancer initiating cells","volume":"15","author":"Haraguchi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"key20200714001143_b179-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature07589","article-title":"Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation","volume":"457","author":"Zhu","year":"2009","journal-title":"Nature"},{"key":"key20200714001143_b180-ol-0-0-7261","first-page":"19","article-title":"Phenotypic subpopulations of metastatic colon cancer stem cells: Genomic analysis","volume":"6","author":"Botchkina","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"key20200714001143_b181-ol-0-0-7261","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3892\/mmr.2015.3195","article-title":"Aldehyde dehydrogenase 1: A specific cancer stem cell marker for human colorectal carcinoma","volume":"11","author":"Zhou","year":"2015","journal-title":"Mol Med Rep"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:46:57Z","timestamp":1594687617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":181,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7261","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}